Camden Cuts 'Did Not Attend' Rates with Integrated Care

EMISClinicians in north London are breaking down inter-professional barriers and reducing ‘did not attend’ (DNA) rates for patients with serious long term conditions. Their clinical commissioning group (CCG) is using data-sharing to integrate care across primary and secondary care, and help avoid hospital admissions. Subject to patient consent at the point of care, clinicians in Camden have a secure view of vital medical information held in GP records - using EMIS Web - in these key areas:
  • Community diabetes
  • Community chronic kidney disease
  • Community joint CKD/Diabetes
  • Community Geriatrician
  • Frailty MDT
  • Community heart failure
  • Community chronic obstructive pulmonary disease
  • Memory Service
  • improving access to psychological therapies (IAPT)

Using the system's search and reports facility, clinicians treating 1407 patients in the diabetes service have reduced the DNA rate from 26 per cent in 2012 to 10 per cent in 2013. It is also helping them to triage care more effectively.

Specialist diabetes nurse Vanessa Sawmynaden said: "Being able to view the GP record means I can check past consultations, history, results and information from hospital appointments - data that is frequently missing from referral letters. We can also track if a patient is seeing another diabetes team, for example in hospital. This enables us not only to prevent duplication of care, but also coordinate it more effectively."

Search and reports has also enabled managers to keep track of DNAs among 70 frail elderly patients. Operations manager Agnes Rieu said: "Patients had been used to going to the hospital, and now they are being seen in community clinics instead. Activity reports revealed where DNA rates were high and we realised there was a job to do in educating patients about accessing the new community-based service."

Clinicians say the data sharing technology is essential to help them manage their caseload and make better clinical decisions.

"EMIS Web Community has helped us break down barriers in our multidisciplinary meeting," said GP Dr Stuart Mackay-Thomas, the CCG's Frailty Lead. "Up to date medical notes from the GP means we are much better informed to make the right decisions about care for these vulnerable patients who have a range of complex needs. It is a stable and reliable platform."

Community teams are also using the technology to create care plans for patients which are then sent electronically to their GP, keeping them fully informed about specialist treatment outside the practice. Ms Rieu added: "EMIS Web has brought benefits for everyone: patients, clinicians & commissioners. It is so intuitive: just look at the screen and everything you need is there."

Related news articles:

About EMIS
EMIS is part of EMIS Group - the UK leader in connected healthcare software and services. EMIS systems hold over 40 million patient records and are used by nearly 6,000 healthcare organisations - from GP practices to community, child and mental health services. 53%* of GP practices in the UK use an EMIS system.

Founded by two forward-thinking GPs, EMIS helps clinicians share vital information, facilitating better, more efficient healthcare and supporting longer and healthier lives.

The company's flagship EMIS Web system enables secure shared access to a patient's whole-life electronic health record. It is the most widely-used GP clinical system in the UK.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...